Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing

8 Sept 2023

Abstract excerpt

Objectives Significant progress has been made in the treatment of patients with pulmonary adenocarcinoma (ADCA) based on molecular profiling. However, no such molecular target exists for squamous cell carcinoma (SQCC). An exome sequence may provide new markers for personalized medicine for lung cancer patients of all subtypes. The current study aims to discover new genetic markers that can be used as universal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37694353
DOI: 10.3233/cbm-220211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencingPMID 37694353Read ↗

Identification of Molecular Biomarkers Associated with Non-Small-Cell Lung Carcinoma (NSCLC) Using Whole-Exome Sequencing AnalysisSemantic proximity Read ↗

Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.Semantic proximity Read ↗

Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung AdenocarcinomasSemantic proximity Read ↗

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer.Semantic proximity Read ↗

Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors.Semantic proximity Read ↗

Mutation profile of non-small cell lung cancer revealed by next generation sequencing.Semantic proximity Read ↗

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Semantic proximity Read ↗

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.Semantic proximity Read ↗

Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.Semantic proximity Read ↗

The potential clinical benefit of routine comprehensive genomic profiling in non-small cell lung cancer for the detection of prognostic co-mutations - A multicenter next generation sequencing study.Semantic proximity Read ↗

Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.